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Purpose: Testicular microlithiasis (TM) is an uncommon pathologic condition that is 
commonly diagnosed by scrotal ultrasonography. Indirect evidence suggests that this
syndrome may be associated with an increased risk of testicular malignancy and 
infertility.
Materials and Methods: A total of 1,439 patients undergoing scrotal ultrasound during 
a 6-year, 5-month period (January 2003 to May 2009) were retrospectively reviewed. 
Any possible association of TM with pathologic findings was assessed. Among patients 
with TM, further grading of TM with testicular cancer and semen analysis of the in-
fertile group with TM were also performed.
Results: TM was diagnosed in 87 patients (6.0%) out of a total of 1,439. Of all established 
pathologic entities, only testicular malignancy and infertility were meaningfully asso-
ciated with TM. There was no significant difference in the prevalence of testicular can-
cer between each grade. Seminal profiles (sperm count, motility, morphology, and white 
blood cell count) were not found to be statistically different between infertile men with 
and without TM.
Conclusions: The prevalence of TM in symptomatic men was found to be 6.0% with sig-
nificant co-occurrence of TM, testicular cancer, and infertility. Further grading of TM 
does not seem to be essential with regard to the detection of patients with testicular 
cancer and TM. TM showed no significant effect on the seminal profiles of infertile men.
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Testicular microlithiasis (TM) is an uncommon pathologic 
condition that is commonly diagnosed by scrotal ultra-
sonography [1,2]. The characteristic ultrasound (US) ap-
pearance of TM involves multiple bright foci, 1 to 2 mm in 
diameter, that are limited to the testicles. There is little or 
no acoustic shadowing, and microliths are either randomly 
distributed throughout the testicle or limited to only part 
of the testicle. TM has been seen in patients with testicular 
malignancy or various nonmalignant entities such as cryp-
torchidism, varicoceles, testicular torsion, Klinefelter’s 
syndrome, pulmonary alveolar microlithiasis, neuro-
fibromatosis, AIDS, intratubular germ cell neoplasia, and 
most frequently, infertility [3,4]. The clinical importance 
of TM arises from its possible association with testicular 
cancer and infertility [3,5-8]. Priebe and Garret first re-
ported the phenomenon in 1970, after seeing bilateral, dif-
fuse testicular calcification on a pelvic X-ray of a 4-year-old 
boy [9]. Since then, other authors have tried to link patho-
logical findings of testicular calcification in testicular tu-
mors and infertility to the US diagnosis of TM. Despite 
these reports, however, the relationship between TM and 
testicular cancer and infertility has been largely anecdotal 
and without predictive value. The lack of current proven 
follow-up strategies for patients with TM basically stems 
from ignorance of the exact prevalence of symptomatic and 
asymptomatic populations and ambiguity in the cause-ef-
fect relationship of TM with other potentially associated 
conditions.Korean J Urol 2011;52:172-177
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FIG. 1. Ultrasonographic image of testicular microlithiasis: limited.
FIG. 2. Ultrasonographic image of testicular microlithiasis: 
grade 1.
FIG. 3. Ultrasonographic image of testicular microlithiasis: 
grade 2.
FIG. 4. Ultrasonographic image of testicular microlithiasis: 
grade 3.
　The objectives of the present study were as follows: (1) 
to report the prevalence of TM in a symptomatic population 
from the Republic of Korea who were undergoing testicular 
ultrasonography; (2) to identify associated pathologic enti-
ties, especially testicular cancer and infertility; (3) to eval-
uate the role of further TM grading in the prevalence of as-
sociated testicular cancer; and (4) to study the seminal pro-
file of TM patients.
MATERIALS AND METHODS
All patients (n=1,439) undergoing scrotal US during a 
6-year, 5-month period (January 2003 to May 2009) were 
included. Scrotal ultrasonography was done in longi-
tudinal and transverse sections by using a scanning device 
with a high-frequency linear array transducer and a center 
frequency of 14 MHz (SIEMENS ACUSON Sequoia 512 
system, Germany). In patients without infertility, the in-
dications for US were scrotal signs and symptoms such as 
palpable mass, pain, and swelling. All pathologic entities 
of patients who had undergone US were recorded. To iden-
tify possible associations with TM, analysis was performed 
by retrospective review of the medical records and US 
images. We defined TM as multiple (more than 2) calcifica-
tions smaller than 2 mm (no acoustic shadowing) inside the 
testicular parenchyma on US [3,4,10]. The presence of TM, 
the number of lesions, the involvement of both testicles in 
relation to symptoms, and the coexistence of other lesions 
were studied. Patients with TM were divided as follows: 3 
or 4 microliths=limited (Fig. 1); 5-10 microliths=grade 1 
(Fig. 2); 11-20 microliths=grade 2 (Fig. 3); and ＞20 micro-
liths=grade 3 (Fig. 4) [11,12]. Solitary and two microcalculi 
or multiple coarse calcifications were not included in the 
analysis. We also recorded laterality of TM in addition to 
grade. In cases of testicular cancer accompanying TM, spe-
cific tumor types were pathologically confirmed.
　In the infertile group, all were unable to conceive over the 
course of 1 year. Semen analysis was performed according 
to the World Health Organization criteria of 1999. This 
analysis included sperm count, motility, morphology, and 
white blood cell (WBC) count.
　All statistical analyses were performed with SPSS ver. 
12.0 (SPSS Inc., Chicago, IL, USA). Categorical variables 
were compared by chi-square test and a student’s t-test was 
used for comparison of seminal profile. p-values of ＜0.05 
were considered to indicate a statistically significant 
difference.
RESULTS
Of the 1,439 patients (mean age, 19.1±20.2 years; range, 
0-87 years) who underwent scrotal US during the study pe-
riod, various pathologic findings were found such as tes-
ticular cancer (n=57, 4.0%), hydrocele (n=547, 38.0%), 
cryptorchidism (n=310, 21.5%), epididymitis (n=199, 13.8%), 
varicocele (n=143, 9.9%), testicular atrophy (n=46, 3.2%) 
including epididymal cysts or dilation, testicular fibrosis, 
and normal manifestation (Table 1).
　Testicular microlithiasis was diagnosed in 87 of the 1,439 
patients (6.0%). The mean age of these patients was 26.2± Korean J Urol 2011;52:172-177
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TABLE 1. Testicular microlithiasis and abnormalities identified 
on scrotal ultrasound 
Scrotal 
abnormalities 
No. of patients 
with TM (%)
Hydrocele 547 31 (5.7)
Cryptorchidism 310   7 (2.3)
Epididymitis 199   6 (3.0)
Varicocele 143 14 (9.8)
Testicular cancer 57   15 (26.3)
Total 1,439 87
The total number of patients does not exactly match the sum of 
scrotal abnormalities because of the additional minor scrotal ab-
normalities and normal testis and scrotum. TM: testicular micro-
lithiasis
FIG. 5. Flow chart of study population.
TM: testicular microlithiasis.
TABLE 2. Association between testicular cancer, infertility, and 
testicular microlithiasis
 No. of 
patients
TM No TM p-value
Testicular cancer 57 15 42 ＜0.001
Others 1,382 72 1,310
Infertility 60 10 50 0.002
Others 1,379 77 1,302
TM: testicular microlithiasis. p-values of ＜0.05 were considered
to indicate a statistically significant difference.
17.9 years (range, 0-74 years). Among them, testicular can-
cer (n=15, 17.2%), hydrocele (n=31, 35.6%), varicocele (n= 
14, 16.1%), cryptorchidism (n=7, 8.0%), epididymal cysts (n= 
6, 6.9%), epididymitis (n=6, 6.9%), fibrosis, atrophy, in-
guinal hernia, and epididymal dilation were found. Of the 
87 patients with TM, 18 (20.7%) were found to have limited 
TM, 16 were grade 1 (18.4%), 26 were grade 2 (29.9%), 27 
were grade 3 (31.0%), and unilateral and bilateral TMs 
were detected in 28 (32.1%) and 59 (67.8%) patients, respec-
tively. All detected TMs were ipsilateral to the associated 
abnormalities.
　In 15 patients with testicular cancer and TM, the histo-
pathologic diagnosis was classic seminoma in 6 patients, 
6 mixed germ cell tumors, 2 teratomas, and 1 yolk sac 
tumor. All 15 patients with testicular cancer and TM had 
classic TM, which meant more than five microliths per 
transducer field. Applying this to the grading system, it 
was found that there was no limited TM in testicular cancer 
with TM. Of the 15 patients with testicular cancer and TM, 
grades 1, 2, and 3 consisted of 3 (20%), 7 (46.7%), and 5 
(33.3%) patients, respectively (Fig. 5).
　There was no significant difference in the prevalence of 
testicular cancer between grades (p=0.72). Among the US 
examinations performed in 60 patients, 10 cases were ac-
companied by TM (16.6%). Of all established pathologic en-
tities, only testicular cancer was meaningfully associated 
with TM (Table 2). The prevalence of TM in testicular can-
cer was 26.3% (15/57) compared with 5.2% (72/1,382) in pa-
tients without testicular cancer (p＜0.001). 
　In 60 cases of infertility (mean age, 33.7±4.6 years; range, 
27-45 cases), 33 had varicocele (55%) and the rest had tes-
ticular atrophy, epididymal cysts, testicular fibrosis, and 
other afflictions. 
　All patients showed abnormal semen quality in semen 
analysis according to World Health Organization criteria. 
Among them, 10 cases were accompanied by TM, a preva-
lence rate of 16.7% (10/60) compared to 5.6% (77/1,439) in 
others (p=0.002) (Table 2). Of the 10, 5 were found to be limi-
ted TM, 1 was grade 1, 2 were grade 2, and 2 were grade 
3 TM. There was no significant difference in the presence 
of other pathologies in those with or without TM (p=0.68). 
Furthermore, seminal profiles (sperm count, motility, mor-
phology, and WBC count) were not statistically different 
between infertile men with and without TM (Table 3).Korean J Urol 2011;52:172-177
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TABLE 3. Semen analysis results
Parameter TM No TM p-value
Sperm count (million/ml) 21.1±22.3  37.3±49.8 0.19
Motility (a＋b, %) 23.1±22.1  29.0±26.9 0.24
Morphology (normal, %) 48.0±32.8  44.6±31.8 0.95
WBC (million/ml) 0.7±1.1  2.2±2.3 0.10
TM: testicular microlithiasis, WBC: white blood cell. p-values of 
＜0.05 were considered to indicate a statistically significant 
difference.
DISCUSSION
Testicular microlithiasis is a rare, asymptomatic finding 
suggested to be associated with various benign and malig-
nant urological pathologies and genetic anomalies that are 
usually found incidentally during unrelated US exami-
nations. Doherty et al reported the first use of real-time US 
to diagnose TM [2]. In the current study, the prevalence of 
TM was found to be 6.0% (87/1,439). The reported preva-
lence of TM has varied widely and has been generally pre-
sented as 0.5% to 9%. In their retrospective review of 1710 
scrotal US scans, Höbarth et al documented 11 cases of TM 
(0.6%) in a population undergoing examination for varico-
cele, hypogonadism, and epididymal cysts [13]. In their ret-
rospective review of 1,100 US scans performed for in-
fertility, pain, or masses, Ganem et al found TM in 2% [14]. 
Middleton et al reviewed US data from 1,079 patients at 
their institution and found a prevalence of 0.68% [15]. This 
wide range partially comes from the recent introduction of 
high-frequency probes and the sensitization of radiologists 
and urologists to the problem [2]. But much more im-
portantly, the vast majority of studies have investigated 
patients examined for testicular pathology. Virtually no 
true screening test for TM in an asymptomatic population 
has ever been performed except in two published reports. 
Peterson et al performed screening US scans on 1,504 
healthy nonsymptomatic males and reported a prevalence 
of 5.6% [16]. More recently, Serter et al found the preva-
lence of TM in an asymptomatic population to be 2.4% after 
screening 2,179 US scans [17]. Despite these findings, the 
true incidence in the general population remains unclear.
　Although the true incidence of TM is not yet known, TM 
has become a concern for the practicing urologist because 
of its possible correlation with testicular cancer. The coex-
istence of many benign and malignant pathologies with TM 
has been reported, and some authors have recognized that 
TM may be associated with a variety of nonneoplastic con-
ditions, such as cryptorchidism, chromosomal anomaly, 
and atrophy. However, the most commonly held views in 
the literature are those that support a correlation between 
TM and testicular cancer [5,15,18].
　We retrospectively reviewed all US cases and evaluated 
whether there was any possible significant association be-
tween TM and pathologic entities. Of all detected testicular 
pathologies, only testicular cancer showed a significant dif-
ference in prevalence. Previous ultrasonography studies 
showed a prevalence of TM ranging from 16.9% to 48.3%. 
In our study, we found 15 cases with TM out of 57 (26.3%) 
testicular cancers versus 72 cases with TM out of 1,382 
(5.2%) patients without testicular cancer (p＜0.001). His-
torically, frequently reported testicular cancer subtypes 
have been seminoma, teratoma, and mixed germ cell tu-
mors in decreasing order. However, we found six patients 
with seminoma and another six with mixed germ cell 
tumors.
　The correlation between TM and testicular tumors has 
been documented extensively in the literature [11,13,16]. 
The association between TM and malignancy was first 
highlighted in 1982 by Ikinger et al, who examined tes-
ticular specimens from 92 postoperative patients (43 with 
malignant and 49 with nonmalignant disease) [19]. Micro-
calcifications were found in 32 (74%) tumor specimens but 
only 8 (16%) benign specimens. Höbarth et al found tumors 
coexisting with TM in 44% of the 42 cases of TM [13]. Backus 
et al, in a cross-sectional retrospective study, reviewed 42 
cases of TM and their association with identified intra-
testicular abnormalities. They noted that 40% of patients 
with TM on US had associated tumors [11]. In a larger ser-
ies, Otite et al reviewed the records of 3,026 patients who 
had undergone scrotal US. Thirty percent of their patients 
with TM were diagnosed with testicular tumors [18]. On 
the other hand, Song et al reviewed 1,088 patients who un-
derwent ultrasonography [20]. In that study, TM was 
found in 6% and 5.8% of the testicular cancer patients and 
the noncancer controls, respectively, in the children’s 
group (p=0.152). In the adult group, 11.6% and 3.3% of the 
patients in the respective groups were found to have TM 
(p=0.001) [20]. To overcome the limitations of the majority 
of published reports, which have been retrospective in na-
ture, several authors have performed prospective fol-
low-up studies of patients with TM. Although many pub-
lished reports found subsequent testicular cancer develop-
ment in men who had been previously diagnosed with TM 
[4,18,21], the relationship between TM and testicular can-
cer remains unresolved due to several drawbacks of those 
studies. The majority of the prospective studies that have 
reported subsequent tumor occurrences were performed in 
a relatively small group (mostly less than 40) and involved 
short follow-up periods (mostly less than 4 years). More im-
portantly, by carefully analyzing the reports that found 
subsequent tumor occurrence in patients with TM, most 
cases had other predisposing factors for the development 
of testicular tumors, such as cryptorchidism, testicular 
atrophy, or previous contralateral testicular tumors. Finally, 
several other follow-up studies have not shown new tumor 
cases [4,11,14,16]. 
　Another important aim of our study was to evaluate the 
impact of grading on the prevalence of TM. Because there 
has been no accurate prevalence and a lack of agreed upon 
clinical importance of TM, further classifying was sug-
gested to help to understand the nature of TM. Generally, 
TM has been accepted as classic TM when at least one im-Korean J Urol 2011;52:172-177
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age shows five or more microliths [10]. Patients who have 
at least one microliths and do not meet the criteria for clas-
sic TM have been considered to have limited TM [12]. 
Further classification of TM as done in our study was also 
suggested by Backus et al [11]. Presently, the number of 
microliths required to obtain a diagnosis of TM has been 
agreed upon at five and above for each sonographic plane 
[11,13]. However, in cases with smaller numbers of micro-
liths that were associated with malignancy [22], we docu-
mented all microliths except 1 or 2 that could be an in-
cidental finding without pathological significance. As we 
investigated the further grading of TM according to the 
number of microliths per US image, we found no difference 
in the prevalence between grades 1, 2, and 3 in accordance 
with the reports by Sanli et al [10]. In that study, they re-
viewed 4,310 cases with classic TM and further graded TM 
as in the present study; however, there was no significant 
difference between grades. Bennett et al compared the 
rates of testicular cancer in patients with 5 to 10 microliths 
per image (grade 1) with those having more than 10 micro-
liths per image (grade 2 and 3) and reported no significant 
difference between the two groups [23]. Therefore, we con-
cluded that further grading of TM is not essential in pa-
tients with TM. But this should be carefully interpreted be-
cause the relatively small number of cases of testicular can-
cer with TM may limit the power of this result. Because 
there were only five bilateral TM cases in 15 tumor cases 
with TM, we couldn’t determine the clinical significance of 
laterality with respect to TM. Several other studies have 
shown that bilateral TM is associated with the pre-invasive 
stage of germ cell testicular cancer more so than unilateral 
[5,24].
　The relationship between TM and infertility is not well 
understood. Testicular microlithiasis, which is frequently 
seen with testicular cancer, may be associated with in-
fertility [5-8]. Theoretically, decreased fertility could be ex-
pected because 30% to 60% of seminiferous tubules can be 
obstructed by intratubular concretions, which is consid-
ered to be a pathogenesis of TM. Infertile patients with TM 
may have significant reductions in sperm migrations and 
motility compared with those with minimal micro-
calcification [7]. However, although some authors have re-
ported abnormal semen parameters in infertile men with 
TM [1,8], others have found no significant difference 
among infertile men with or without TM [13,25]. In the 
present study, we found a prevalence rate of TM of 16.6% 
(10/60) in the infertile group, which fits into the currently 
reported prevalence (0.8 to 20%) and confirms a significant 
co-occurrence (p=0.002). There were no significant differ-
ences in sperm count, motility, or morphology in terms of 
sperm function between infertile men with or without TM. 
Our results suggest that, although there is a significant as-
sociation between TM and infertility, it seems unwise to ex-
pect an adverse effect of TM on seminal profile. However, 
this could be confounded by other accompanying patholo-
gies like varicoceles. We also assume that the relatively low 
grade of TM in the infertile group might have affected the 
seminal profile comparison. Thomas et al reported that 
cases with minor degrees of calcification generally had bet-
ter sperm count and sperm migration tests than did those 
with marked calcification. There may therefore be a rela-
tionship between the degree of calcification and poor sperm 
function [26]. On the other hand, in the study by Sakamoto 
et al, which showed a similar seminal profile comparison 
result as in the present study, the authors mentioned that 
the degree of subfertility in patients with TM was variable 
and may reflect underlying testicular dysgenesis or con-
comitant intrascrotal abnormality [25]. 
　Apart from the adverse effect on seminal profile, TM it-
self might be a risk factor for testicular cancer in infertile 
men who are already in a high-risk group [5,6]. In a study 
of 263 subfertile men by de Gouveia Brazao et al, the au-
thors demonstrated that carcinoma in situ (CIS) was pres-
ent in 20% of infertile men with bilateral TM. This was com-
pared to 1% in the overall infertile population [5]. Patients 
with TM and infertility might have two risk factors for tes-
ticular cancer. Skakkebaek et al interpreted this increased 
risk for developing malignancy as the so-called testicular 
dysgenesis syndrome [27]. Those authors suggested that 
in men with TM, or other criteria for testicular dysgenesis 
such as testicular maldescent, atrophy, low sperm count, 
or inhomogeneous US appearance, the risk for CIS should 
be examined [28]. Testicular microlithiasis, infertility, and 
testicular cancer all therefore seem to be interlinked. 
Under these circumstances, it seems convincing that par-
ticular attention should be paid to TM patients who already 
have significant risk factors for the development of tes-
ticular cancer, such as infertility, cryptorchidism, or in-
fertility, especially in diffuse bilateral cases [3,29].
　This study had the following limitations. First, it was a 
retrospective review and was based on a preselected pop-
ulation undergoing US for myriad conditions that have the 
potential for increased incidence of germ cell tumors, which 
limits the power of the results. Second, we presented the 
prevalence of TM on the basis of a symptomatic population. 
Together with the retrospective nature of the present 
study, this makes it difficult to determine the true in-
cidence and natural course of TM. To the best of our knowl-
edge, only two prospective studies are available to de-
termine the incidence and natural history of TM in a 
healthy asymptomatic population [14,15].
CONCLUSIONS
The prevalence of TM in the symptomatic population in our 
study was found to be 6.0%. Our study indicates the sig-
nificant co-occurrence of TM, testicular cancer, and infer-
tility.
　Even if a true cause-effect relationship between TM and 
testicular cancer exists, further grading of TM does not 
seem to be essential with regard to the detection of patients 
with testicular cancer and TM. Furthermore, TM showed 
no significant impact on seminal profiles in infertile men 
in the present study; however, it should be carefully in-Korean J Urol 2011;52:172-177
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terpreted with respect to other accompanying pathologies.
　Despite a significant pool of knowledge, the natural his-
tory and clinical significance of TM are not well understood. 
To reach a definitive conclusion about TM, further larger 
prospective and collaborative studies are required.
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